Alacrity Biosciences' Series A Round

Alacrity Biosciences raised a round of funding on March 14, 2007. Investors include Paramount BioSciences.

Alacrity Biosciences is a biopharmaceutical company focused on acquiring, developing and commercializing therapeutics to treat ophthalmic diseases that threaten vision and reduce patient quality of li…

Articles about Alacrity Biosciences' Series A Round: